Table 13.
Placebo ∆ | Chitosan ∆ | p-Value Chitosan vs. Placebo | |
---|---|---|---|
All subjects (μg/mg) | 0.29 ± 122.85 | −28.64 ± 102.15 * | 0.5541 # |
% subjects decrease | 67.3 | 60.7 | 0.5622 # |
% subjects increase | 32.7 | 39.3 | |
Change vs. baseline | |||
Spearman R | −0.3006 | −0.6175 | |
Spearman p-value | 0.0257 | <0.0001 | |
Difference in slope (p-value) | 0.1934 $ | <0.0001 $ | 0.2153 & |
∆ Wilcoxon p-value expressing the significance of the change compared to zero, * p < 0.05, # data are expressed as p-values using the Mann–Whitney test, $ value expresses whether slope is different from zero, & value expresses whether slopes under Chitosan and placebo treatments are different.